Evidence map›Paper›PMID 36583195›Full record

ArticleClinical case reports2022

A Tunisian patient with CLCN2-related leukoencephalopathy.

Dina Ben Mohamed, Zacharia Saied, Samia Ben Sassi, Mariem Ben Said, Fatma Nabli, Afef Achouri, Cyrine Jeridi, Saber Masmoudi, Rim Amouri

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Identification of a novelFrontiers in genetics · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dina Ben MohamedMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Zacharia SaiedMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Samia Ben SassiMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Mariem Ben SaidLaboratoire Procédés de Criblage Moléculaire et Cellulaire Centre de Biotechnologie de Sfax Sfax Tunisia.
Fatma NabliMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Afef AchouriMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Cyrine JeridiMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.
Saber MasmoudiLaboratoire Procédés de Criblage Moléculaire et Cellulaire Centre de Biotechnologie de Sfax Sfax Tunisia.
Rim AmouriMolecular Neurobiology and Neuropathology Department National Institute Mongi Ben Hamida of Neurology La Rabta Tunisia.ORCID https://orcid.org/0000-0001-5641-5748
National Institute of Neurology Mongi-Ben Hamida · TNCentre of Biotechnology of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CLCN2-related leukoencephalopathy (CC2L OMIM#: 615651) is a recently identified rare disorder. It is caused by autosomal recessive mutations in the

Indexed as

CLCN2CLCN2‐related leukoencephalopathyMRI

Identifiers

PMID36583195
PMCPMC9792646
OpenAlexW4312198428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.